Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Assura two piece ostomy system ileostomy bag midi 50mm opaque
23941009581
|
Assura two piece ostomy system ileostomy bag midi 50mm opaque | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system ileostomy bag midi 60mm clear
23941009477
|
Assura two piece ostomy system ileostomy bag midi 60mm clear | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system ileostomy bag midi 60mm opaque (12443)
23941009582
|
Assura two piece ostomy system ileostomy bag midi 60mm opaque (12443) | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system ileostomy bag midi 60mm opaque (2746)
23941009482
|
Assura two piece ostomy system ileostomy bag midi 60mm opaque (2746) | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system urostomy bag maxi 40mm opaque
23941009515
|
Assura two piece ostomy system urostomy bag maxi 40mm opaque | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system urostomy bag maxi 50mm opaque
23941009516
|
Assura two piece ostomy system urostomy bag maxi 50mm opaque | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Assura two piece ostomy system urostomy bag maxi 60mm opaque
23941009517
|
Assura two piece ostomy system urostomy bag maxi 60mm opaque | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
AT10 250micrograms/ml oral solution
0906040K0BBAAAA
|
AT10 | Dihydrotachysterol | Nutrition and Blood | No data available |
|
Atazanavir 100mg capsules
0503010L0AAACAC
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 150mg capsules
0503010L0AAAAAA
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 200mg capsules
0503010L0AAABAB
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atazanavir 300mg / Cobicistat 150mg tablets
0503010ALAAAAAA
|
Atazanavir/cobicistat | Atazanavir and cobicistat | Infections | No data available |
|
Atazanavir 300mg capsules
0503010L0AAADAD
|
Atazanavir | Atazanavir | Infections | No data available |
|
Atenix 100 tablets
0204000E0BCADAC
|
Atenix | Atenolol | Cardiovascular System | No data available |
|
Atenix 25 tablets
0204000E0BCAEAG
|
Atenix | Atenolol | Cardiovascular System | No data available |
|
Atenix 50 tablets
0204000E0BCACAB
|
Atenix | Atenolol | Cardiovascular System | No data available |
|
Atenix Co 100 tablets
020400040BDABAB
|
Atenix Co | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | No data available |
|
Atenix Co 50 tablets
020400040BDAAAA
|
Atenix Co | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | No data available |
|
Atenolol 10mg/5ml oral liquid
0204000E0AAASAS
|
Atenolol | Atenolol | Cardiovascular System | No data available |
|
Atenolol 12.5mg/5ml oral liquid
0204000E0AAAQAQ
|
Atenolol | Atenolol | Cardiovascular System | No data available |
|
Atenolol 25mg / Bendroflumethiazide 1.25mg capsules
0204000A0AAAAAA
|
Atenolol/bendroflumethiazide | Atenolol with thiazides | Cardiovascular System | No data available |
|
Atenolol 3.125mg/5ml oral liquid
0204000E0AAAMAM
|
Atenolol | Atenolol | Cardiovascular System | No data available |
|
Atenolol 3mg/5ml oral liquid
0204000E0AAAPAP
|
Atenolol | Atenolol | Cardiovascular System | No data available |
|
Atenolol 50mg/5ml oral liquid
0204000E0AAARAR
|
Atenolol | Atenolol | Cardiovascular System | No data available |
|
Atenolol 5mg/10ml solution for injection ampoules
0204000E0AAADAD
|
Atenolol | Atenolol | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.